The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
In this article, Gareth Jenkins from Changeology Group Ltd examines how data-driven methodologies – supported by real NHS case studies – can foster meaningful, sustainable change.
New research by Global Action Plan, coinciding with this year's Clean Air Day, 21 June, found that primary and nursery school children were being exposed to 30% more toxic pollution compared to adults when walking along busy roads
Isabel Proaño Gómez, Communications Manager at European Federation of Allergies and Airways Diseases Patients’ Associations (EFA) explains why air matters, for everybody, everywhere (H2)
Over the last few years, it has been discovered that too many patients are being treated as if they were emergencies. Is it all bad for the organisation though? Join Tilly Bailey & Irvine Law Firm as they weigh up both the positive and negative aspects of the NHS
Prof. Martin Schrappe, President of the European Society for Paediatric Oncology details the vital role of collaboration in tackling paediatric cancer across Europe
Amanda White, Director of Communications and Marketing at Health Data Research UK, reflects on the opportunities to harness the UK’s strengths in data science to transform health
Helen McShane, Professor of Vaccinology at The Jenner Institute, University of Oxford reveals the current status of tuberculosis vaccine development in the world today.
David Bearman, M.D., Executive VP of the American Academy of Cannabinoid Medicine details the research priorities for cannabis, one of the most thoroughly studied plants of all time
Boris Šustaršič, President of the European Alliance of Neuromuscular Disorders Associations shares his thoughts on the key issues around muscular dystrophy (MD) in Europe today
Jonathan Evans, communications manager at the Association of British HealthTech Industries provides an interesting update on the health technology sector, including the extent to which the UK exports to the EU every year in this vein.
Cecilia Van Cauwenberghe from Frost & Sullivan shares her expertise on the world of nanomedicines, with a special focus on depicting human health risks hindering clinical translation.
Shyh-Jye Lee (Jeff), Ph. D, President of the Taiwanese Society of Developmental Biology (TSDB) explains the way in which developmental biology impacts upon our lives
Cecilia Van Cauwenberghe from the TechVision Group at Frost & Sullivan provides a detailed analysis of the present concerns and foreseen opportunities around muscular dystrophy (MD)
Marcin Rodzinka, Project Coordinator at Mental Health Europe explains how transparency between the pharma industry and health professionals can influence the quality of mental health care in Europe today
